Neuroendocrine Tumor Treatment Market - Top Companies and Manufacturers

Companies Dominating the Neuroendocrine Tumor Treatment Market

BoehringerIngelheim International GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Hutchison MediPharma Limited,
AVEO Oncology
Pfizer, Inc.
IpsenPharma
Tarveda Therapeutics
Progenics Pharmaceuticals
Novartis AG
Eli Lilly & Company
Ipsen Pharma

Browse Key Market Insights with Data Illustration:

Neuroendocrine Tumor Treatment Market Size & Share, Growth Trends 2037

In the News

Eli Lilly & Company to supply its human insulin active pharmaceutical ingredient (API) to IABL at a reduced cost in order to facilitate the manufacturing of insulin in Bangladesh.
Boehringer Ingelheim teamed up with 3T Biosciences to identify and create cutting-edge cancer treatments to meet the significant unmet patient needs. Further, the collaboration will combine the industry-leading 3T-TRACE (T-Cell Receptor Antigen and Cross-Reactivity Engine) discovery platform from 3T Biosciences with Boehringer Ingelheim's two-pronged research approach combining cancer cell-directed and immune cell-targeting compounds.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of neuroendocrine tumor treatment is assessed at USD 2.17 billion.

The neuroendocrine tumor treatment market size was over USD 2.04 billion in 2024 and is projected to reach USD 5.62 billion by 2037, witnessing around 8.1% CAGR during the forecast period i.e., between 2025-2037. Increasing incidence of neuroendocrine cancer will boost the market growth.

North America industry is poised to account for largest revenue share of 38% by 2037, backed by high R&D spending by pharmaceutical corporations and regional governments in the region.

The major players in the market include BoehringerIngelheim International GmbH, Hutchison MediPharma Limited, AVEO Oncology, Pfizer, Inc., IpsenPharma, Tarveda Therapeutics, Progenics Pharmaceuticals, Novartis AG, Eli Lilly & Company, Ipsen Pharma

Neuroendocrine Tumor Treatment Market - Top Companies and Manufacturers

Companies Dominating the Neuroendocrine Tumor Treatment Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the neuroendocrine tumor treatment market worth?

Why is the demand for neuroendocrine tumor treatment growing?

Which region dominated the majority of neuroendocrine tumor treatment industry share?

Who are the top neuroendocrine tumor treatment companies?